Parametric Portfolio Associates’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$139K Sell
211
-16
-7% -$8.52K ﹤0.01% 3512
2021
Q4
$132K Sell
227
-4
-2% -$2.9K ﹤0.01% 3510
2021
Q3
$124K Sell
231
-41
-15% -$20K ﹤0.01% 3507
2021
Q2
$108K Buy
272
+42
+18% +$13.7K ﹤0.01% 3475
2021
Q1
$65K Buy
230
+40
+21% +$11.8K ﹤0.01% 4008
2020
Q4
$45K Buy
190
+33
+21% +$8.34K ﹤0.01% 3953
2020
Q3
$45K Hold
157
﹤0.01% 3874
2020
Q2
$53K Buy
157
+31
+25% +$9.35K ﹤0.01% 3859
2020
Q1
$30K Buy
+126
New +$37.5K ﹤0.01% 3876

Other funds holding LNAI

Parametric Portfolio Associates's LNAI Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Lunai Bioworks (LNAI) stake by 7% in Q1 2022, selling an estimated $8.52K and leaving 211 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3512.

Parametric Portfolio Associates first reported a position in LNAI in Q1 2020 and has held it in 9 quarters since. 43 funds tracked by Wall St. Rank hold LNAI as of Q1 2022.

  • Parametric Portfolio Associates held 211 shares of Lunai Bioworks worth $139K as of Q1 2022.
  • Parametric Portfolio Associates sold 16 Lunai Bioworks shares in Q1 2022, an estimated $8.52K.
  • Lunai Bioworks made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3512 holding.
  • Parametric Portfolio Associates first reported a position in Lunai Bioworks in Q1 2020 and has held it in 9 quarters since.
  • 43 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.